Combination of an iron chelator and an immunosuppressant and use thereof

Details for Australian Patent Application No. 2009216757 (hide)

Owner Novartis AG

Inventors Leismann, Oliver

Agent Davies Collison Cave

Pub. Number AU-A-2009216757

PCT Pub. Number WO2009/103727

Priority 08151642.9 19.02.08 EP

Filing date 18 February 2009

Wipo publication date 27 August 2009

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 39/04 (2006.01) General protective or antinoxious agents

Event Publications

26 August 2010 PCT application entered the National Phase

  PCT publication WO2009/103727 Priority application(s): WO2009/103727

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009216764-Solar cell system with encapsulant

2009216751-A method of treating an ocular pathology by applying high intensity focused ultrasound and device thereof